Sort
261,768 grants matching “gene therapy”
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$905,028Haian Fu · Emory University · U01 · FY2019 · CA
UBM: Integrated Analysis of Genetic and Cellular Networks
$905,000Peter W Bates · Michigan State University · · FY2005 · MPS
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
$904,991Dianne B McKay · Scripps Research Institute, The · R01 · FY2023 · DK
Genomic characterization and development of therapies for pediatric sarcoma
$904,989John Shern · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Genomic dissection of tumor heterogeneity and progression
$904,989John Shern · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A chemical chaperomics platform for AD
$904,900Gabriela Chiosis · Sloan-Kettering Inst Can Research · R56 · FY2018 · AG
High-throughput single-cell sorting and sequencing with PACS
$904,733Dennis J Eastburn · Mission Bio, Inc. · R44 · FY2015 · HG
Regulatory T Cells in Autoimmune Disease
$904,627David A. Hafler · Brigham And Women'S Hospital · U19 · FY2006 · AI
Mouse Mutant Resource
$904,588Leah Rae B Donahue · Jackson Laboratory · P40 · FY2012 · OD
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$904,588Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$904,560Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$904,507Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
GENE THERAPY FOR PREVENTION OF PHANTOM LIMB PAIN FOLLOWING EXTREMITY INJURIES
$904,486University Of Miami · · FY2018 · Defense Health Agency
Ca2+ signaling Networks in Health and Disease
$904,357Mohamed Trebak · University Of Pittsburgh At Pittsburgh · R35 · FY2023 · HL
HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction
$904,298Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Genetic modifiers of Duchenne Muscular Dystrophy
$904,269Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · NS
African-ancestry Breast Cancer Genetic Consortium
$904,115Wei Zheng · Vanderbilt University Medical Center · R01 · FY2025 · CA
Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis
$904,058Buel Rodgers · Aavogen, Inc. · R44 · FY2022 · AG
Rational Integration of Polygenic Risk Scores (RIPS)
$903,936Josh F. Peterson · Vanderbilt University Medical Center · R01 · FY2024 · HG
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$903,852Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
Optimized Adaptation of Simian-tropic R5 HIV Clade C to Pig-tailed Macaques
$903,811Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R56 · FY2013 · AI
Development of a novel renalase agonist for the treatment of acute pancreatitis
$903,732Eliot Ohlstein · Bessor Pharma, Llc · R44 · FY2025 · DK
Pathophysiology of PTH-related Protein (1-36) in Humans
$903,687Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · DK
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$903,615Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2008 · HL
NEI Genetic Engineering Core
$903,592Lijin Dong · National Eye Institute · ZIC · FY2013 · EY